Joachim Van Calster

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

Quan Dong Nguyen, Pauline T. Merrill, Glenn J. Jaffe et al. · The Lancet · 2016 · 512 citations · Full text

Medicine, Immunology, Ophthalmology +16

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis

Andrew D. Dick, James T. Rosenbaum, Hassan Al-Dhibi et al. · Ophthalmology · 2018 · 266 citations · Full text

Medicine, Immunology, Ophthalmology +17

Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III

Eric B. Suhler, Alfredo Adán, Antoine P. Brézin et al. · Ophthalmology · 2018 · 198 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Outcomes of different management options for malignant glaucoma: a retrospective study

Veroniek Debrouwere, Peter Stalmans, Joachim Van Calster et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2011 · 128 citations

Medicine, Ophthalmology, Surgery +14

Oximetry in glaucoma: correlation of metabolic change with structural and functional damage

Evelien Vandewalle, Luís Abegão Pinto, Ólöf Birna Ólafsdóttir et al. · Acta Ophthalmologica · 2013 · 116 citations · Full text

Medicine, Ophthalmology, Vision Science +17